The Effects of COVID-19 on Private Equity in Healthcare – A Review of Selected Niche Investment Areas

February 5, 2021

At the beginning of 2020, it seemed the slow but steady drumbeat of provider consolidation would continue on its natural course. Then COVID-19 struck, forcing the delay or cancellation of acquisitions as provider-based businesses dealt with furloughs, credit facility defaults and endless stresses.

In hindsight nearly a year later, the pandemic appears more an accelerant than a change of prognosis for the sector, with stronger companies surviving, even flourishing, and struggling companies facing existential crisis. Meanwhile, private equity investment in healthcare has continued to evolve.

For details about the evolving market and a look at 2021 and beyond, download a new McGuireWoods white paper analyzing the effects of the pandemic on private equity in 22 key healthcare investment niches.